Travis Mickle
Chairman at KemPharm Denmark A/S
Net worth: 254 110 $ as of 2024-04-29
Profile
Travis C.
Mickle was the founder of Zevra Therapeutics, Inc. founded in 2006, where he held the title of President & Director in 2023.
Currently, he is the Chairman at KemPharm Denmark A.
In the past, he worked as the Director-Drug Discovery & Chemical Development at New River Pharmaceuticals, Inc. from 2003 to 2005.
Dr. Mickle received his undergraduate degree from Simpson College in 1995 and his doctorate degree from the University of Iowa in 2000.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0.13% | 2024-03-21 | 56,219 ( 0.13% ) | 254 110 $ | 2024-04-29 |
Travis Mickle active positions
| Companies | Position | Start |
|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Chairman | 2022-05-12 |
Former positions of Travis Mickle
| Companies | Position | End |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Executive Officer | 2023-04-24 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 2005-09-30 |
Training of Travis Mickle
| Simpson College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |
- Stock Market
- Insiders
- Travis Mickle